DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1391-1399

  Gäbele, Erwin ^a   Dostert, Karin ^a   Hofmann, Claudia ^a   Wiest, Reiner ^a   Schölmerich, Jürgen ^a   Hellerbrand, Claus ^a   Obermeier, Florian ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Colitis; Hepatic stellate cell; Intestinal defensin; Liver fibrosis; LPS; NASH; TLR

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CRAMP PROTEIN; DOCUSATE SODIUM; INTERLEUKIN 17; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PAI 1 PROTEIN; PROTEIN; PROTEIN P47; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION; HEPATITIS; HISTOPATHOLOGY; LIPID DIET; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CATHELICIDINS; COLITIS; DEXTRAN SULFATE; DIET, HIGH-FAT; DNA PRIMERS; FATTY LIVER; GENE EXPRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052477222     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.02.035     Document Type: Article

References (39)

1. A. Poonawala, S.P. Nair, and P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 2000 689 692
2. C.P. Day Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 50 2002 585 588
3. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
4. A.E. Reid Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
5. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, and J.M. Long IKK-beta links inflammation to obesity-induced insulin resistance Nat Med 11 2005 191 198
6. A.M. Diehl, Z.P. Li, H.Z. Lin, and S.Q. Yang Cytokines and the pathogenesis of non-alcoholic steatohepatitis Gut 54 2005 303 306
7. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 2006 3015 3025
8. J.Y. Lee, J. Ye, Z. Gao, H.S. Youn, W.H. Lee, and L. Zhao Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids J Biol Chem 278 2003 37041 37051
9. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 2001 675 680
10. A.J. Wigg, I.C. Roberts-Thomson, R.B. Dymock, P.J. McCarthy, R.H. Grose, and A.G. Cummins The role of small intestinal bacterial overgrowth, intestinal permeability, endotox-aemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis Gut 48 2001 206 211
11. P. Brun, I. Castagliuolo, A.R. Floreani, A. Buda, L. Blasone, and Palu.G. Increased Gut 55 2006 1212
12. Y. Adachi, L.E. Moore, B.U. Bradford, W. Gao, and R.G. Thurman Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1995 218 224
13. R.G. Thurman II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin Am J Physiol 275 1998 G605 G611
14. E. Seki, S. De Minicis, C.H. Osterreicher, J. Kluwe, Y. Osawa, and D.A. Brenner TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332
15. C.A. Rivera, P. Adegboyega, N. van Rooijen, A. Tagalicud, M. Allman, and M. Wallace Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J Hepatol 47 2007 571 579
16. K. Miura, Y. Kodama, S. Inokuchi, B. Schnabl, T. Aoyama, and H. Ohnishi Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice Gastroenterology 2010
17. P. Brun, I. Castagliuolo, V.D. Leo, A. Buda, M. Pinzani, and G. Palu Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis Am J Physiol Gastrointest Liver Physiol 292 2007 G518 G525
18. L. Miele, V. Valenza, G. La Torre, M. Montalto, G. Cammarota, and R. Ricci Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887
19. F. Obermeier, N. Dunger, U.G. Strauch, C. Hofmann, A. Bleich, and N. Grunwald CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation Gastroenterology 129 2005 913 927
20. Y. Masubuchi, and T. Horie Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis Drug Metab Dispos 32 2004 437 441
21. N. Matsuzawa, T. Takamura, S. Kurita, H. Misu, T. Ota, and H. Ando Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet Hepatology 46 2007 1392 1403
22. F. Obermeier, N. Dunger, L. Deml, H. Herfarth, J. Scholmerich, and W. Falk CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice Eur J Immunol 32 2002 2084 2092
23. A. Bleich, L.M. Janus, A. Smoczek, A.M. Westendorf, U. Strauch, and M. Mahler CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction Gastroenterology 136 2009 278 287
24. E. Gäbele, M. Muhlbauer, C. Dorn, T.S. Weiss, M. Froh, and B. Schnabl Role of TLR9 in hepatic stellate cells and experimental liver fibrosis Biochem Biophys Res Commun 376 2008 271 276
25. E. Gäbele, M. Froh, G.E. Arteel, T. Uesugi, C. Hellerbrand, and J. Scholmerich TNFalpha is required for cholestasis-induced liver fibrosis in the mouse Biochem Biophys Res Commun 378 2009 348 353
26. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
27. T. Amann, F. Bataille, T. Spruss, M. Muhlbauer, E. Gäbele, and J. Scholmerich Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma Cancer Sci 100 2009 646 653
28. + T cells which prevent intestinal inflammation in the SCID transfer model of colitis Gut 54 2005 1428 1436
29. R. Kirsch, V. Clarkson, R.C. Verdonk, A.D. Marais, E.G. Shephard, and B. Ryffel Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency J Gastroenterol Hepatol 21 2006 174 182
30. A.G. Ruiz, F. Casafont, J. Crespo, A. Cayon, M. Mayorga, and A. Estebanez Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis Obes Surg 17 2007 1374 1380
31. U. Hofer, E. Schlaepfer, S. Baenziger, M. Nischang, S. Regenass, and Schwendener.R. Inadequate PLoS Pathog 6 2010 e1000867
32. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
33. P. Brandtzaeg Mucosal immunity: induction, dissemination, and effector functions Scand J Immunol 70 2009 505 515
34. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, and R.G. Holzer Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
35. A. Karlsson, A. Jagervall, M. Pettersson, A.K. Andersson, P.G. Gillberg, and S. Melgar Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters Int Immunopharmacol 8 2008 20 27
36. R. Raqib, P. Sarker, P. Bergman, G. Ara, M. Lindh, and D.A. Sack Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic Proc Natl Acad Sci USA 103 2006 9178 9183
37. S. Seki, T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J Hepatol 37 2002 56 62
38. G. Robertson, I. Leclercq, and G.C. Farrell Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress Am J Physiol Gastrointest Liver Physiol 281 2001 G1135 G1139
39. J.A. Badwey, and M.L. Karnovsky Active oxygen species and the functions of phagocytic leukocytes Annu Rev Biochem 49 1980 695 726